Invivyd Inc (IVVD) is not a strong buy at this time for a beginner investor with a long-term strategy. While the company has shown revenue growth, its declining net income, EPS, and gross margin, combined with hedge fund selling and lack of positive news or catalysts, suggest limited immediate upside potential. The technical indicators and options data also do not provide a compelling case for entry at the current price.
The MACD is positive but contracting, RSI is neutral at 64.406, and moving averages are converging, indicating no strong trend. The stock is trading near resistance levels (R1: 1.745) with limited upside potential in the short term.

Revenue increased by 24.51% YoY in Q4 2025, showing some growth potential.
Net income dropped by 39.98% YoY, EPS fell by 73.33% YoY, and gross margin declined slightly. Hedge funds are selling heavily, and there are no recent positive news or significant insider activity.
In Q4 2025, revenue increased to $17.2M (up 24.51% YoY), but net income dropped to -$11.07M (down 39.98% YoY). EPS fell to -0.04 (down 73.33% YoY), and gross margin declined slightly to 93.37% (down 1.47% YoY).
No recent analyst rating or price target changes available.